参考文献/References:
[1] Boyer TD, Haskal ZJ. The role of Transjugular Intrahepatic Por-tosystemic Shunt (TIPS) in the management of portal hyper-tension: update 2009 [J]. Hepatology, 2010, 51: 306.
[2] Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study [J]. Radiology, 1969, 92: 1112 - 1114.
[3] Rossle M, Richter GM, Noldge G, et al. Performance of an intrahepatic portocaval shunt (PCS) using a catheter technique: A case report [J]. Hepatology, 1988, 8: 1348.
[4] D＇Amico G, Luca A. TIPS is a cost effective alternative to surgical shunt as a rescue therapy for prevention of recurrent bleeding from esophageal varices [J]. J Hepatol, 2008, 48: 387 - 390.
[5] Yang Z, Han G, Wu Q, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetra-fluoroethylene-covered stents versus bare stents: a meta-analysis [J]. J Gastroenterol Hepatol, 2010, 25: 1718 - 1725.
[6] Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis [J]. N Engl J Med, 2010, 362: 823 -832.
[7] Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis [J]. Hepatology, 2007, 46: 922 - 938.
[8] Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al. Influe-nce of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding [J]. Hepatology, 2004, 40: 793 - 801.
[9] García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding [J]. N Engl J Med, 2010, 362: 2370 - 2379.
[10] Gonzalez R, Zamora J, Gomez-Camarero J, et al. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis [J]. Ann Intern Med, 2008, 149:109 -122.
[11] Rosemurgy AS, Bloomston M, Clark WC, et al. H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals [J]. Ann Surg, 2005, 241:238 - 246.
[12] Henderson JM, Boyer TD, Kutner MH, et al. Distal splen-orenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial [J]. Gastroenterology, 2006, 130: 1643 - 1651.
[13] Boyer TD, Henderson JM, Heerey AM, et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt [J]. J Hepatol, 2008, 48:407 - 414.
[14] Lo GH, Liang HL, Chen WC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding [J]. Endoscopy, 2007, 39: 679 - 685.
[15] Gines P, Cardenas A, Arroyo V, et al. Management of cirrhosis and ascites [J]. N Engl J Med, 2004, 350: 1646 - 1654.
[16] Salerno F, Camma C, Enea M, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data [J]. Gastroenterology, 2007, 133: 825 -834.
[17] Maleux G, Perez-Gutierrez NA, Evrard S, et al. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study [J]. Acta Gastroenterol Belg, 2010, 73: 336 - 341.
[18] Siegerstetter V, Deibert P, Ochs A, et al. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients [J]. Eur J Gastroenterol Hepatol, 2001, 13: 529 - 534.
[19] Dhanasekaran R, West JK, Gonzales PC, et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis [J]. Am J Gastroenterol, 2010, 105: 635 - 641.
[20] Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome [J]. N Engl J Med, 2004, 350: 578 - 585.
[21] Garcia-Pagan JC, Heydtmann M, Raffa S, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients [J]. Gastroenterology, 2008, 135: 808 - 815.
[22] Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome [J]. Ann Intern Med, 2009, 151: 167 - 175.
[23] 张文广, 丁鹏绪, 韩新巍. 布一加综合征介入治疗的现状与进展[J]. 介入放射学杂志, 2011, 20: 70 - 74.
[24] 韩国宏, 何创业, 殷占新, 等. 经颈内静脉肝内门腔静脉分流术治疗Budd-Chiari综合征[J]. 介入放射学杂志, 2008, 17: 239 -242.
[25] Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder [J]. N Engl J Med, 2008, 358: 2378 - 2387.
[26] Chevallier P, Novelli L, Motamedi JP, et al. Hepatopulmonary syndrome successfully treated with transjugular intrahepatic portosystemic shunt: a three-year follow-up [J]. J Vasc Interv Radiol, 2004, 15: 647 - 648.
[27] Brensing KA, Textor J, Perz J, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study [J]. Gut, 2000, 47: 288 - 295.
[28] Guevara M, Gines P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems [J]. Hepatology, 1998, 28: 416 - 422.
[29] Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albu-min, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome [J]. Hepatology, 2004, 40: 55 - 64.
[30] Han G, Qi X, He C, et al. Transjugular intrahepatic portosy-stemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis [J]. J Hepatol, 2011, 54:78 - 88.
[31] 祁兴顺, 韩国宏, 樊代明. 经颈内静脉肝内门体分流术治疗门静脉血栓的现状[J]. 介入放射学杂志, 2010, 19: 917 - 921.
[32] Conn HO, Lindenmuth WW, May CJ, et al. Prophylactic porta-caval anastomosis. [J]. Medicine, 1972, 51:27-40.
[33] Sze DY, Strobel N, Fahrig R, et al. Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid cross-sectional/angiographic imaging [J]. J Vasc Interv Radiol, 2006, 17:711-715.
[34] Bai M, Qi X, Yang Z, et al. Predictors of hepatic encepha-lopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review [J]. J Gastroenterol Hepatol, 2011, In press.
[35] Maleux G, Heye S, Verslype C, et al. Management of trans-jugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study [J]. J Vasc Interv Radiol, 2007, 18:986-993.
[36] Kerlan RK Jr, LaBerge JM, Baker EL, et al. Successful rev-ersal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts [J]. J Vasc Interv Radiol, 1995, 6: 917 - 921.
[37] Forauer AR, McLean GK. Transjugular intrahepatic portosystemic shunt constraining stent for the treatment of refractory postprocedural encephalopathy: a simple design utilizing a Palmaz stent and Wallstent [J]. J Vasc Interv Radiol, 1998, 9: 443 - 446.
[38] Kochar N, Tripathi D, Ireland H, et al. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy [J]. Gut, 2006, 55: 1617 - 1623.
[39] Ochs A. Transjugular intrahepatic portosystemic shunt [J]. Dig Dis, 2005, 23: 56 - 64.
相似文献/References:
[1]褚建国,朴龙松,陈肇一,等.家兔门静脉系统不同部位血氨浓度比较的前瞻性研究[J].介入放射学杂志,1999,(01):40.
[2]李彦豪.介入性血管内导管药盒系统植入术[J].介入放射学杂志,1999,(02):4.
[3].第18届国际放射学大会论文摘要选编[J].介入放射学杂志,1994,(01):39.
[4]张子曙,黄祥龙,沈天真,等.经颈静脉肝内门体分流术[J].介入放射学杂志,1994,(04):239.
[5]张金山.TIPSS术中值得注意的几个问题[J].介入放射学杂志,1994,(04):187.
[6]俞文强,刘子江,袁建华,等.晚期肝癌患者生存二年以上的治疗体会[J].介入放射学杂志,1996,(01):44.
[7]孟祥文,张进,李黄宗,等.肝癌肝动脉与门脉肝静脉主支分流的介入治疗[J].介入放射学杂志,1996,(01):43.
[8]秦永福,宁路江,齐颖,等.原发性肝癌合并门脉癌栓的经导管碘油化疗栓塞[J].介入放射学杂志,1996,(04):223.
[9]艾昭东,王 维,高 峰,等.不同途径肝内微囊移植对肝功能及肝血流影响的对比研究[J].介入放射学杂志,2011,(07):555.
AI Zhao-dong,WANG Wei,GAO Feng,et al.The impact of intrahepatic microcapsule transplantation on the liver function and liver blood flow: a comparative study of different transplantation approaches[J].journal interventional radiology,2011,(06):555.
[10]龚少娟,邢冬娟,徐爱民,等.经皮经肝钢圈选择性门静脉栓塞术在肝门部胆管癌术前的应用[J].介入放射学杂志,2011,(07):534.
GONG Shao-juan,XING Dong-juan,XU Ai-min,et al.Percutaneous transhepatic selective embolization of portal vein with steel coils: its preoperative application for hilar cholangiocarcinoma[J].journal interventional radiology,2011,(06):534.
[11]祁兴顺,韩国宏,樊代明.经颈静脉肝内门体分流术治疗门静脉血栓的现状[J].介入放射学杂志,2010,(11):916.
QI Xing-shun,HAN Guo-hong,FAN Dai-ming.Transjugular intrahepatic portosystemic shunt for the treatment of portal vein thrombus: its current status[J].journal interventional radiology,2010,(06):916.